Owners, management and financials
CVR: 39432714
DKK -20,487
Gross profit
Net result: DKK -31,867
MOESTRUP HOLDING 2007 ApS (25-33,32%), MØLLER HOLDING 2007 ApS (25-33,32%)
2 more
CVR · view owners
Niels Jonas Heilskov Graversen
Board: Jens Kristian Damsgaard (chair) and 3 members
CVR · view management
Active
Founded 9 March 2018
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: DeLiver Pharma ApS
CVR · 09/03/2018
View the full event history
DeLiver Pharma ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Niels Jonas Heilskov Graversen. The board consists of Jens Kristian Damsgaard (chair), Holger Jon Møller, Niels Jonas Heilskov Graversen and Søren Kragh Moestrup. The company's owners include MOESTRUP HOLDING 2007 ApS, MØLLER HOLDING 2007 ApS and PHIDEAS ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -20,487 and a net result of DKK -31,867 compared with DKK -21,682 the year before. Equity in the 2025 report amounted to DKK 163,221.
Selskabets formål er at drive virksomhed med medicinsk udvikling samt enhver i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -32K | 176K | 163K | 0 | |
| 202401/01/2024 – 31/12/2024 | - | -22K | 206K | 195K | 0 | |
| 202301/01/2023 – 31/12/2023 | - | 107K | 271K | 217K | 0 | |
| 202201/01/2022 – 31/12/2022 | - | -29K | 121K | 109K | - | |
| 202101/01/2021 – 31/12/2021 | - | -147K | 150K | 139K | - | |
| 202001/01/2020 – 31/12/2020 | - | -114K | 255K | 246K | - | |
| 201901/01/2019 – 31/12/2019 | 79K | -12K | 230K | 220K | - |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of DeLiver Pharma ApS is 39432714.
The owners of DeLiver Pharma ApS include MOESTRUP HOLDING 2007 ApS, MØLLER HOLDING 2007 ApS and PHIDEAS ApS.
The management of DeLiver Pharma ApS consists of Niels Jonas Heilskov Graversen.
The board of DeLiver Pharma ApS consists of Jens Kristian Damsgaard, Holger Jon Møller and Niels Jonas Heilskov Graversen, with Jens Kristian Damsgaard as chair.
In 2025, DeLiver Pharma ApS reported a gross profit of DKK -20,487.
DeLiver Pharma ApS had an average of 0 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
DeLiver Pharma ApS has published its annual report for 2025. Gross profit came to DKK -20,487, and the net result was DKK -31,867.
Address changed to Sanatorievej 8, 5600 Faaborg (May 29, 2026).
Contact info changed: new phone: 21733311, new email: [email protected] (May 29, 2026).
Address changed to Fuglevej 21 21, 8592 Anholt (January 7, 2026).
DeLiver Pharma ApS has published its annual report for 2024. Gross profit came to DKK -10,302, and the net result was DKK -21,682.
DeLiver Pharma ApS has published its annual report for 2023. Gross profit came to DKK 118,663, and the net result was DKK 107,283.
DeLiver Pharma ApS has published its annual report for 2022. Gross profit came to DKK -17,951, and the net result was DKK -29,331.
DeLiver Pharma ApS has published its annual report for 2021. Gross profit came to DKK -21,884, and the net result was DKK -146,911.
DeLiver Pharma ApS has published its annual report for 2020. Gross profit came to DKK -19,597, and the net result was DKK -113,852.
DeLiver Pharma ApS has published its annual report for 2019. Revenue came to DKK 79,000, and the net result was DKK -12,094.
DeLiver Pharma ApS has published its interim report for the period March 9, 2018 to December 31, 2018.
As of March 9, 2018, Jens Kristian Damsgaard has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Niels Jonas Heilskov Graversen has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Søren Kragh Moestrup has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Holger Jon Møller has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Niels Jonas Heilskov Graversen is registered as director of DeLiver Pharma ApS.
As of March 9, 2018, MOESTRUP HOLDING 2007 ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, MØLLER HOLDING 2007 ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, PHIDEAS ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, SCIENCE VENTURES DENMARK A/S is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
DeLiver Pharma ApS was founded on March 9, 2018.
Companies in the same industry and area
